Babak Litkouhi, MD
Gynecologic Oncology Physician · Stanford, CA
Babak Litkouhi, MD is a gynecologic oncology physician with a practice address in Stanford, California, and NPI 1003877002, issued on Mar 29, 2006. Check the license (California C160189, as entered in NPPES) on the Medical Board of California; the Medicare figures below come from public CMS files.
- Name
- Babak Litkouhi
- Credential
- MD
- Primary taxonomy
- Gynecologic Oncology Physician 207VX0201X
- License numbers
- C160189 CA
54011 CT
224807 MA
25MA8279400 NJ
Self-reported in NPPES; status is on the state search - Practice location
- 300 Pasteur Dr, Stanford, CA 94305
- Phone
- (650) 723-4000
- Enumerated
- Mar 29, 2006
- Record last updated
- Apr 26, 2024
- Fax
- (203) 785-7931
- Medicaid ID
- 0138321 NJ
- Medicare enrollment
- Enrolled (PECOS I20190426001158); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
Also registered at 300 Pasteur Dr
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Cooper Aakhus, MDEmergency Medicine Physician1194351007
- Oliver Aalami, M.D.Vascular Surgery Physician1225229024
- Alistair Aaronson, MDInternal Medicine Physician1457628760
- Sumaira Aasi, MDMOHS-Micrographic Surgery Physician1780675181
- Fahim Abbasi, M.D.Internal Medicine Physician1841484037
- Mohamad Abbass, MDNeurological Surgery Physician1679492151
Verify Babak Litkouhi in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersMedical Board of California
Search for license C160189Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
29% fewer Medicare Part D claims than the average gynecologic oncology physician in 2024
139 Medicare Part D claims for 38 beneficiaries, against an average of 195 among the 1,475 providers of this specialty who prescribed in Part D. Brand-name drugs were 15% of claims.
Most prescribed
- Ondansetron Hcl16 claims
- Estradiol13 claims
- Megestrol Acetate13 claims
- Prochlorperazine Maleate13 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The practice group's MIPS final score for 2023 (Medicare payment program): 76.5 of 100
The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $29.76
1 payment: food and beverage; the largest payer was Ethicon US, LLC. The 1,199 providers of this specialty with any payment received $6,387.20 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
One hospital affiliation
- Stanford Health CareStanford, CA · Acute Care Hospitals5 of 5 stars
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through); hospitals matched to CMS Hospital General Information (Care Compare) (data.cms.gov). Star ratings are CMS hospital ratings, not ratings of this provider.
Gynecologic Oncology Physician providers in California
There are 176 gynecologic oncology physician records in California.
Other gynecologic oncology physician records in California
- Lisa Abaid, M.D., M.P.H.Newport Beach, CA1295943132
- Alireza Abidi, M.D.Sacramento, CA1215919477
- Federico Alva, M.D.Northridge, CA1649200379
- Edwin Alvarez, M.D.Sacramento, CA1710197330
- Kristen Anderson, M.D., PH.D.Moreno Valley, CA1447575568
- Melanie Arora, M.D.Apple Valley, CA1578889283
- Fikret Atamdede, M.D.Torrance, CA1578502480
- Samuel Ballon, M.D.Los Gatos, CA1760408173
- Alice Barr, MDSacramento, CA1982109286
- Lisa Bean, M.D.Calexico, CA1760782817
Common questions
What is Babak Litkouhi, MD's NPI number?
Babak Litkouhi, MD's National Provider Identifier (NPI) is 1003877002, issued on Mar 29, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Babak Litkouhi, MD located?
The NPPES record lists a practice address at 300 Pasteur Dr, Stanford, CA, 94305. Phone: (650) 723-4000. Providers update this record themselves, so call before visiting.
How can I verify Babak Litkouhi, MD's license?
NPPES lists California license number C160189, as entered by the provider. Search the Medical Board of California at https://www.mbc.ca.gov/License-Verification/default.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Babak Litkouhi, MD prescribe under Medicare Part D?
In 2024, Babak Litkouhi, MD had 139 Medicare Part D claims for 38 beneficiaries; the average among gynecologic oncology physician prescribers was 195. Part D covers Medicare prescriptions only.
What is Babak Litkouhi, MD's MIPS final score?
The 2023 MIPS final score is 76.5 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.